2023 annual financial data
MiNK Therapeutics 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -22,921,105 USD and net income was -22,457,859 USD.
Operating cash flow was -15,762,512 USD.
Get free MiNK Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,921,105 USD
- Net income
- -22,457,859 USD
- Operating cash flow
- -15,762,512 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all MiNK Therapeutics financial years